Anavex Life Sciences (AVXL) Financials

$2.85

$-0.01 (-0.35%)

As on 08-Sep-2026 16:18EDT

Market cap

$265 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	30.64	51.41	52.88	55.76	50.99	42.00
Operating Profit (EBIT)	-30.64	-51.41	-52.88	-47.50	-50.99	-42.00
Other Income	--	--	--	--	2.42	4.33
Profit before Tax	-24.03	-46.38	-43.00	-47.50	-47.62	-37.64
Provision for Tax	0.01	-0.65	-2.29	-0.01	0.36	0.27
Profit after Tax (Net Income)	-24.04	-46.38	-43.00	-47.49	-47.98	-37.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-47.51	-47.98	-37.91

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	112.45	94.87	120.26	141.85	142.49	150.82
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.04	3.89	4.84	7.30	4.27	0.00
Current Liabilities	7.69	8.95	15.30	12.53	10.21	10.80
Total Liabilities	127.83	103.82	135.57	154.39	152.70	161.62

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	--	--	--	3.36	3,546.74	0.02
Current Assets	120.14	103.82	135.57	154.39	152.70	161.62
Total Assets	127.83	103.82	135.57	154.39	152.70	161.62
Total Debt*	--	--	--	--	--	--
Net Current Assets	112.45	94.87	120.26	141.85	142.49	150.82

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	-39.04	-30.81	-27.79	-24.24	-30.38
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	9.43	11.98	29.65	21.29	153.24
Net Cash Inflow / Outflow	--	--	--	--	-2.95	122.86

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-0.27	-0.54	-0.51	-0.60	-0.62	-0.50
Cash EPS ($)	--	-0.54	-0.51	-0.60	-0.62	-0.50
Adjusted Book Value ($)	--	1.10	1.43	1.78	1.85	1.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.45	-0.37	-0.35	-0.32	-0.40
Free Cash Flow per Share ($)	--	-0.45	-0.37	-0.35	-0.32	-0.40

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	-43.11	-32.81	-33.40	-32.71	-42.58
ROE (%)	-20.11	-43.11	-32.81	-33.40	-32.71	-42.58
ROA (%)	-20.00	-38.75	-29.66	-30.93	-30.53	-38.65
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,983.05	-874.72
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	4.64	0.25	36.36	-29.52
Net Profit Growth (%)	50.09	-7.85	9.45	1.02	-26.56	-44.25
EPS Growth (%)	52.32	-0.05	0.14	0.05	-0.25	-0.22
Book Value Growth (%)	15.42	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-16.48	-11.10	-11.00	-16.54	-35.99
Price / Book Value	2.35	8.06	3.97	3.68	5.57	9.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.54	-14.27	-8.02	-7.82	-13.54	-32.20
Close Price ($)	2.59	8.90	5.68	6.55	10.32	17.95
High Price ($)	13.99	14.44	10.31	15.24	23.73	31.50
Low Price ($)	2.41	5.03	3.25	6.52	7.13	3.95
Market Cap ($ Cr)	265.11	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	15.62	11.60	8.86	12.32	14.95	14.97
Quick Ratio	15.62	--	--	--	--	14.97
Interest Coverage	--	--	--	-49.27	-50.28	-18.53

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.